ePillz.com - A Revolutionary Contraception Is Approved

A Revolutionary Contraception Is Approved

July 18, 2006 - Organon USA –

Implanon, a new, state-of-the-art and the first of a kind contraceptive, has been recently approved by the American Food and Drug Administration. It is informed in the official press-release by Organon USA company, the producer of new contraceptives. “We are excited about the FDA’s approval for Implanon, which represents a real advance in contraceptive technology and will provide women with a new level of confidence in contraception.” said the representative of Organon.

Implanon represents a brand-new technology in women’s contraception. In fact, it is a small rod (a size of a matchstick), made of polymer, which is inserted under the skin of a woman’s upper arm. When implanted, the product continuously releases a low, steady dose of progestogen (etonogestrel) for a period of three years. Thus Implanon ensures the birth protection for as long as 3 years with only one operation. It seems to have many benefits in comparison with the traditional birth control pills, which should be taken regularly on a daily basis.

To prevent the pregnancy Implanon works in several ways: it stops the release of an egg from the ovary; it also changes the mucus in the cervix and this change may keep sperm from reaching the egg; finally, Implanon changes the lining of your uterus. Working as described above, the new contraceptive is able to guarantee very high rate of effectiveness. The company says that only 1 woman per 100 may have chances to become pregnant while using Implanon.

The most common side effect, associated with Implanon use, is certain changes in menstrual periods. A woman may experience more bleeding, less bleeding or no bleeding at all, while using Implanon. Other side effects include headache, acne, depression or mood changes.

In case a woman with implanted contraceptive decides to remove it, this can be done at any time by a specialist. After the removal, woman’s fertility rapidly returns to its usual level. The procedures of inserting and removing Implanon are fulfilled under the local anesthesia only by those specialists, who attended clinical training courses organized and sponsored by the producer of this new type of contraception. Organon says that the training programs are planned to start in the USA later this year, so Implanon contraceptives are expected to become widely available in 2007.

Though Implanon has been approved in the USA only this year, it had already been available in over 30 countries throughout the world since the product launch in 1998. The company says that their Implanon has been used by more than 2.5 million women worldwide.

Organon Company, being a human healthcare business unit of Akzo Nobel, develops and manufactures medical products in its four core therapeutic fields: fertility, gynecology, anesthesia and neuroscience.

Nick

External resources
http://www.webmd.com/content/article/125/115848.htm
http://www.organon-usa.com/news/fdaapprovesimplanonetonogestrelimplant.asp
http://www.implanon-usa.com
http://www.rwh.org.au/rwhcpg/womenshealth.cfm?doc_id=4844